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A growing body of literature suggests that there is a link between periodontitis and sys-
temic diseases. These diseases include cardiovascular disease, gastrointestinal and colo-
rectal cancer, diabetes and insulin resistance, and Alzheimer's disease, as well as
respiratory tract infection and adverse pregnancy outcomes. The presence of periodontal
pathogens and their metabolic by-products in the mouth may in fact modulate the im-
mune response beyond the oral cavity, thus promoting the development of systemic
conditions. A cause-and-effect relationship has not been established yet for most of the
diseases, and the mediators of the association are still being identified. A better under-
standing of the systemic effects of oral microorganisms will contribute to the goal of using
the oral cavity to diagnose and possibly treat non-oral systemic disease.Periodontal disease is one of the most common inflam- concern and a mounting burden on the healthcare system [2].matory diseases in adults. In 2010, 3.9 billion people world-
wide were reported to have periodontal disease, with the
prevalence of mild periodontitis being 35% and moderate to
severe periodontitis, 11% [1]. As the global population ages,
periodontal disease has become a significant public healthedical Sciences, Universit
. Ojcius).
g Gung University.
ublishing services by Else
s/by-nc-nd/4.0/).According to the US Centers for Disease Control and Preven-
tion, periodontal disease is considered to be a worldwide
pandemic, causing disability, speech impairment, low self-
esteem, and reduced quality of life [2].y of the Pacific, Arthur Dugoni School of Dentistry, 155 Fifth Street,
vier B.V. This is an open access article under the CC BY-NC-ND
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has attracted the attention from researchers outside of
dentistry due to the potential influence of periodontitis on
initiation and/or progression of several systemic diseases.
Over the years, evidence has accumulated that links oral
diseases with many non-oral and systemic diseases,
including cancer, cardiovascular disease, type 2 diabetes,
respiratory tract infection, adverse pregnancy outcomes,
and neurodegenerative disease [3e5].
For the most part, however, it remains to be established
whether specific periodontal pathogens stimulate development
of the systemic disease, or if the systemic disease causes the
abundance of periodontal pathogens to change. If the patho-
gens cause non-oral disease, then they would represent
obvious targets for therapeutic intervention. But as aminimum,
the presence of periodontal pathogens could be used as diag-
nostic markers to predict susceptibility to non-oral disease.
Periodontal pathogens could promote development of non-
oral disease directly or indirectly. For example, about 30
abundant species in the oral cavity, mainly Gram-negative
anaerobic bacteria, are known to produce endotoxins, which
could directly contribute to systemic disease [6]. Migration of
oral pathogens to the blood stream could also occur in some
cases, such as following surgical procedures. Bacterial accu-
mulation on the teeth due to poor dental hygiene and/or
environmental factors induces a host inflammatory response,
which may result in periodontitis and bone loss [7] but could
also be harmful to the host systemically.Dental plaque, periodontal pathogens and
bacteremia
The most common Gram-negative bacterial genera in the oral
cavity include Treponema, Bacteroides, Porphyromonas, Pre-
votella, Capnocytophaga, Peptostreptococcus, Fusobacterium,
Actinobacillus, and Eikenella [6,8]. Early studies identified Por-
phyromonas gingivalis, Actinobacillus actinomycetemcomitans and
Tannerella forsythia as causative agents in periodontal disease
[9], and much of the research on periodontal disease con-
tinues to focus on these microorganisms. However, more
recent studies have determined that the oral cavity contains
approximately 500e700 prevalent taxa; this microbial com-
munity is referred to as the oral microbiota, oral microflora, or
oral microbiome [8,10]. The oral microbiota is present in
saliva, on gingival epithelium and other inner surfaces of the
oral cavity and concentrated in dental plaque.
The dental plaque is an organized biofilm of microorgan-
isms that are either attached to the tooth surface or to other
microorganisms in a way that allows the microorganisms to
survive and resist host defense mechanisms or antibiotic
treatment [11]. As the biofilm matures, microbial dysbiosis
occurs, causing a progressive shift from Gram-positive to
predominantly Gram-negative anaerobic species, and result-
ing in biofilm formation under the gingival surface [12].
Additionally, sugar metabolism by the dental plaque biofilm
leads to production of organic acids, which play a crucial role
in pH reduction and demineralization of the tooth surface [13].
Thus, frequent sugar consumption is also known to inducedysbiosis of the supragingival microbiota, promoting devel-
opment of carious lesions [12].
Tissue trauma, flossing, dental procedures, or even chewing
foodmay induce breakage of blood vessels in close proximity to
the dental plaque, which can introduce bacteria into the sys-
temic bloodstream [14]. Bacteremia has in fact been observed
following somedental ormedical procedures, and somebacteria
were isolated from the blood after endodontic treatment [15,16].Relationship between oral and non-oral systemic
disease
Many recent studies explore the interrelationship between
oral health, inflammation, and systemic disease (Fig. 1). Oral
microbiota can cause oral inflammation but may also directly
contribute to systemic inflammation, increasing inflamma-
tion through the release of toxins or leakage of microbial
products into the bloodstream. The association between oral
inflammation and systemic inflammation is fundamental to
understanding the detrimental effects of oral inflammation
on several organ systems and the ability of oral disease to
increase the risk of developing non-oral disease. We consider
evidence linking oral disease with some major systemic non-
oral diseases in the sections below.Cardiovascular disease
Cardiovascular disease is considered the leading cause of
death in the U.S. and is amajor cause of disability according to
the CDC. Given its high economic and social impact, the cor-
relation between cardiovascular and periodontal disease has
attracted attention of many researchers. Although various
epidemiological studies have suggested that there may be an
association between periodontitis and cardiovascular disease,
the impact of oral infection on cardiovascular diseases has
remained unclear.
A meta-analysis that combined 5 cohort studies (86,092
patients) showed that individualswith periodontal disease had
1.14 times higher risk of developing coronary heart disease
than the controls, independently of confounding factors [17].
The case-control studies (1423 patients) showed an even
greater risk of developing coronary heart disease (2.22 times)
[17]. This study showed that both prevalence and incidence of
cardiovascular disease are significantly increased in patients
with periodontitis. Moreover, an association between edentu-
lousness and serum antibodies against P. gingivalis and A.
actinomycetemcomitans with coronary heart disease was
observed in a study with 1163 men [18]. An additional study
confirmed the presence of bacterial DNA species in 42 athero-
matous plaques retrievedby endarterectomy [19]. The bacterial
species most commonly found in this study were P. gingivalis,
followed by A. actinomycetemcomitans, T. forsythia, Eikenella cor-
rodens, Fusobacterium nucleatum and Campylobacter rectus [19].
Along similar lines, DNA from periodontal pathogens, such as
P. gingivalis, A. actinomycetemcomitans, Prevotella intermedia, and
T. forsythia, was found in human atherosclerotic plaques, sug-
gesting that these oral pathogens may migrate from the oral
cavity to distant sites of the body [20,21].
Fig. 1 Schematic representation of different systemic diseases and their association with oral pathogens. Periodontal diseases
can predispose individuals to several systemic diseases such as cardiovascular disease, oral and colorectal cancer,
gastrointestinal diseases, respiratory tract infection and pneumonia, adverse pregnancy outcomes, diabetes and insulin
resistance, and Alzheimer's disease. The arrows show systemic diseases that can be affected by the oral cavity, and the
periodontal pathogens associated with each systemic disease.
b i om e d i c a l j o u r n a l 4 2 ( 2 0 1 9 ) 2 7e3 5 29More recently, studies in an animal model of athero-
sclerosis using hyperlipidemic mice infected with P. gingi-
valis and Treponema denticola demonstrated that infection
with these bacteria is associated with alveolar bone
loss and aortic atherosclerosis [22,23]. After oral infection,
P. gingivalis and T. denticola induced a systemic immune
response, and bacterial genomic DNA was found in the oral
epithelium, aorta and within systemic organs [22,23].
Additionally, P. gingivalis evades innate immune detection
via Toll-like receptor (TLR)-4, facilitating chronic inflam-
mation in the vasculature [24]. It was also demonstrated
that P. gingivalis, by means of its secreted outer membrane
vesicles, can induce platelet aggregation in human sam-
ples, which could be responsible for thrombus formation
in vivo [25]. Interestingly, other oral pathogens such as
A. actinomycetemcomitans, T. forsythia, C. rectus, F. nucleatum,
P. intermedia and T. denticola failed to aggregate platelets
when tested for aggregation activity [26], suggesting that
only P. gingivalis expresses virulence factors that can induce
platelet aggregation.
In summary, several oral pathogens are associated with a
higher risk of cardiovascular disease in humans, and studies
in mice support the possibility that infection with the oral
pathogens may lead to the disease.Respiratory tract infection and pneumonia
Pneumonia is a significant cause ofmorbidity andmortality in
patients of all ages, especially in the old and immunocom-
promised. The lung infections can be caused by bacteria,
fungi, viruses and parasites. Microorganisms can infect the
lower respiratory tract by inhalation of infectious aerosols,
spread of infection from contiguous sites, and spread from
extrapulmonary sites. The oral cavity, especially saliva
and dental plaque in patients with periodontal disease, seems
to be a logical source for pathogens to accumulate and
spread to the lower airways. Several oral pathogens have
already been implicated in lung infections, including A. acti-
nomycetemcomitans, Actinomyces israelii, Capnocytophaga spp,
Chlamydia pneumoniae, E. corrodens, F. nucleatum, Fusobacterium
necrophorum, P. gingivalis, P. intermedia and Streptococcus con-
stellatus [27e29].
Respiratory pathogens isolated from dental plaque and
bronchoalveolar lavage fluid from the same patients in the
intensive care unit were shown to be genetically the same,
which reinforces the view that dental plaque could serve as a
significant reservoir for respiratory pathogens [30]. In fact, in-
dividuals with periodontitis are three times more likely to
develop nosocomial pneumonia, compared with patients
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infection, P. gingivalis was responsible for persistent inflam-
matory responses in the lungs involving cell recruitment and
proinflammatory cytokine production [27]. Interestingly, a
study with 40 subjects undergoing orotracheal intubation
showed large quantities ofA. actinomycetemcomitans, P. gingivalis
and T. forsythia in toothed and toothless patients, suggesting
that the oral environment, even without teeth, presents favor-
able conditions for pathogenic bacterial accumulation [32].
The common oral pathogens F. nucleatum and F. necropho-
rum were found to cause a distinct condition beginning with
pharyngitis and leading to respiratory tract infection called
Lemierre's syndrome [28,29]. Interestingly, a cross-sectional
study of students presenting acute sore throat detected F.
necrophorum in 20.5% of subjects and 9.4% of asymptomatic
individuals, which was approximately twice as often as the
usually investigated groupA b-hemolytic streptococcus (10.3%
of patients and 1.1% of asymptomatic subjects) [33]. These
studies suggest that Fusobacterium is a potential pathogen of
the lungs and should be taken into account when investi-
gating airway complications.
Conversely, C. pneumoniae is well-studied as a respiratory
pathogen and has been associated with asthma, bronchitis
and chronic obstructive pulmonary disease [34]. This path-
ogen has also been found in the oral cavity [35,36] and could
probably translocate from the oral cavity to the lower airways,
from where it could disseminate systemically to other sites
such as spleen, heart, and aorta via monocytes through blood
circulation, as suggested in a mouse model [37]. Furthermore,
C. pneumoniae infection has been associated with an increased
risk of atherosclerosis development [38], which could provide
another mechanism whereby pathogens in the oral cavity
contribute to atherosclerosis.
Together, these studies demonstrate that unhealthy oral
cavities can predispose to respiratory infections and suggest
that oral or non-oral pathogens present in the oral cavity
could contribute to respiratory disease.
Oral and colorectal cancer
Cancer accounts for one out of four deaths every year, costing
the US approximately $100 billion in healthcare besides the
emotional and medical burden that it represents to families
and society. In the early 1990s, Helicobacter pylori was recog-
nized as a causative agent of human gastric cancer [39],
becoming the first major bacterial pathogen to be associated
with human cancer [40,41]. In this review, wewill focus on the
relationship between periodontal bacterial pathogens and
cancer.
Ameta-analysis study including 3183 subjects showed that
patients with periodontal disease have an increased suscep-
tibility to oral cancer [42]. More recent studies found a positive
correlation between periodontal disease and pancreatic, head
and neck, and lung cancers [40]. Another study examined one
million randomly selected insurance cases in Taiwan, and
found that patients in the periodontitis cohort exhibited a
higher risk of developing cancer than those in the gingivitis
cohort [43].
Moreover, the periodontal pathogen P. gingivalis was
found at significantly elevated levels in oral squamous cellcarcinoma (OSCC) [44] and esophagus squamous cell carci-
noma (ESCC) patients, but not in healthy mucosa [41]. The
potential role for periodontal pathogens in the induction of
oral cancer was confirmed in an oral-specific chemical carci-
nogenesis animal model [45]. The study showed that the
periodontal pathogens P. gingivalis and F. nucleatum stimulate
tumorigenesis via direct interaction with oral epithelial cells,
and that the effect is mediated by the host innate immune
system [45]. In the case of OSCC, it was demonstrated that P.
gingivalis, but not F. nucleatum, promotes invasion and
metastasis of oral squamous cells by inducing matrix metal-
loproteinase 9 (pro-MMP9) expression [44]. Another study
showed that prolonged and repetitive exposure to P. gingivalis
increases aggressiveness of oral cancer cells via epithelial-
mesenchymal transition-like changes in the cells [46].
Therefore, oral pathogens, specifically P. gingivalis and F.
nucleatum, have been shown to positively correlate with
development of oral cancer, suggesting that they could be
biomarkers for early stages of the disease, or even targets for
prevention of oral cancers in humans.
Colorectal carcinoma (CRC) is the fourth leading cause of
cancer deathsworldwide, and has been associated with a high
abundance of F. nucleatum and Clostridium difficile in the in-
testinal microbiota of colorectal carcinoma patients [47]. A
polymicrobial signature of Gram-negative anaerobic bacteria
was associated with colorectal carcinoma in 130 tissues
analyzed [48]. Gram-negative anaerobic oral pathogens such
as Fusobacterium, Leptotrichia and Campylobacter species were
identified in individuals with tumors [48]. It is thought that
oral F. nucleatum could migrate to and colonize the human
intestinal tract, to cause deleterious inflammatory infections
[47,49]. Furthermore, F. nucleatum was found in higher
numbers in human colonic adenomas relative to surrounding
tissues and in stool samples from patients with CRC,
compared with subjects without CRC [50]. Additionally, in a
mouse model of intestinal tumorigenesis, F. nucleatum
increased tumor multiplicity and selectively recruited tumor-
infiltrating myeloid cells, which can promote tumor progres-
sion [50]. Another mechanistic study showed that levels of F.
nucleatum gradually increased during the colorectal adenoma-
carcinoma sequence in human fecal and mucosal samples
[51]. F. nucleatum's ability to alter the composition of the lumen
microbiota as well as its ability to mediate secretion of cyto-
kines and activate tumorigenesis-related pathways was
demonstrated in mouse models of CRC [51]. In summary,
these data indicate that F. nucleatum promotes a pro-
inflammatory microenvironment that may contribute to
neoplasia progression in colorectal adenoma-carcinoma.
Diabetes mellitus
Diabetes mellitus is a chronic metabolic disorder character-
ized by hyperglycemia due to a defect in insulin production by
pancreatic b cells (type 1 diabetes), a decrease in insulin
sensitivity (type 2 diabetes), or a combination of both [52] that
can affect adults, teenagers and children. Noteworthy, dia-
betes mellitus and periodontitis present a “two-way” associ-
ation in which one affects the other. Chronic infection during
periodontitis can lead to exacerbated and dysregulated in-
flammatory responses, which may result in poor metabolic
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[53]. In fact, individuals with acute bacterial and viral infection
demonstrated severe and long-lasting insulin resistance [54].
This idea was confirmed by a studywith 124middle-agedmen
showing that the burden of enteroviruses and C. pneumoniae
associated strongly with insulin resistance, probably because
of the chronic low-grade inflammation resulting from these
infections [55]. Regarding P. gingivalis infection, a decrease in
gingival vascular function and increased insulin resistance
was observed in a diabetes model in rats [56]. Interestingly,
results from ameta-analysis study suggested that periodontal
treatment leads to an improvement of glycemic control in
type 2 diabetic patients, for at least 3 months [57]. In general,
even though the mechanisms underlying this association are
not completed understood, periodontitis seems to increase
the risk of diabetes due to infection and/or inflammatory re-
sponses [53,58].
Conversely, diabetes can also lead to different complica-
tions such as poor wound healing, retinopathy, nephropathy,
neuropathy, macrovascular disease and periodontitis [52,58].
In fact, diabetic individuals have a threefold increase in the
risk of periodontitis, compared with non-diabetics subjects
[59]. In another study, periodontitis was found in 58% of type
1 diabetes patients and in 15% of non-diabetic controls [60].
When periodontal status in children and adolescents with
type 1 diabetes mellitus was examined, a prevalence of 21%
of gingivitis and 6% of periodontitis was detected; also, pa-
tients having lived more than five years with diabetes mel-
litus type 1 showed more affected sites on periodontal
disease parameters [61].
In summary, a bidirectional association between diabetes
mellitus and periodontal disease has been shown, in which
diabetes enhances the risk for periodontitis, and conversely,
periodontal inflammation negatively affects glycemic control.
Additionally, periodontal treatment improves diabetes
symptoms, confirming their association and the importance
of oral health for the overall organism.
Alzheimer's disease
Alzheimer's disease is a progressive neurodegenerative dis-
ease characterized by a progressive and irreversible impair-
ment in memory, thinking, and language and learning
capacity, which ultimately ends in death [62]. The cognitive
decline has been related to the formation of synaptotoxic b-
amyloid plaques and hyperphosphorylated tau proteins in the
regions of the brain associated with advanced cognitive
functions [62,63]. As shown for diabetes mellitus, Alzheimer's
disease and periodontitis also present a bidirectional rela-
tionship that will be discussed in this section.
A recent comprehensive oral-health study showed that
individuals with brain injury had a higher prevalence of poor
oral health parameters and chronic generalized periodontitis
[64]. The brain, which was thought to have no or diminished
immune responses because of its “immunologic privilege”
status, can undergo different inflammatory processes that
contribute to development of Alzheimer's disease, such as
complement activation and cytokine and chemokine expres-
sion [65]. In fact, inflammation is viewed as the link between
periodontitis and Alzheimer's disease. The presence ofactivated glial cells that produce significant levels of inflam-
matory cytokines is a hallmark of Alzheimer's disease [66].
Besides the direct damage caused by b-amyloid plaques and
tau aggregates, the innate immune response attempts to
purge these aggregates from the brain, but instead aggravates
neurodegeneration [62,63]. Thus, an increase in pro-
inflammatory cytokines is detected in elderly patients with
Alzheimer's disease and periodontitis [67]. Studies using
different anti-inflammatory drugs and cytokines reinforce the
hypothesis that inflammation is a major driver of neuro-
degeneration in Alzheimer's disease, suggesting that nasal
nonsteroidal anti-inflammatory drugs (NSAIDs) might be
effective in slowing the onset of Alzheimer's disease [68]. In
addition, the IL-1 receptor antagonist and immunosuppres-
sive cytokines can protect the brain from further damage and
decrease the rate of Alzheimer's disease progression [69].
The host synthesizes pro-inflammatory cytokines sys-
temically in response to oral bacterial infection, suggesting
that periodontal disease may contribute to the brain inflam-
mation that characterizes Alzheimer's disease [65,70]. Inter-
estingly, lipopolysaccharide (LPS) from periodontal pathogens
such as P. gingivalis and T. denticola was isolated from short-
term postmortem Alzheimer's disease human brains, sug-
gesting that virulence factors from these pathogens could play
a role in development of brain inflammation and Alzheimer's
disease [71]. Moreover, bacteria such as the periodontal
pathogen T. denticola [72] and C. pneumoniae [73,74] were
detected in postmortem Alzheimer's disease brains, suggest-
ing that besides inflammatory mediators, some periodontal
pathogens may invade the brain by crossing the brain-blood
barrier. This was confirmed in animal studies, which
showed the presence of P. gingivalis in mouse brains [75].
Moreover, higher levels of antibodies against A. actino-
mycetemcomitans, P. gingivalis, T. forsythia [70], F. nucleatum and
P. intermedia [76] were observed in elderly patients with Alz-
heimer's disease, compared with healthy controls. Although
these periodontal pathogens seem to be associated with
symptoms of Alzheimer's disease, further longitudinal studies
will be needed to directly link periodontal pathogens (and
antibodies against them) with neurodegeneration in Alz-
heimer's disease.
In summary, poor oral hygiene contributes to chronic
periodontitis and may indirectly increase the risk for Alz-
heimer's disease. Conversely, patients with Alzheimer's dis-
ease present impairments in the ability to maintain proper
oral hygiene or even visit a dentist for professional care, which
enhances the risk for periodontitis. In this sense, it is tempting
to speculate thatmaintaining good oral health could become a
prophylactic measure against Alzheimer's disease.Adverse pregnancy outcomes
Maternal infections are associated with adverse pregnancy
outcomes, including preterm labor, preterm premature
rupture of the membranes, pre-eclampsia, miscarriage, intra-
uterine growth retardation, low birthweight, stillbirth, and
neonatal sepsis [77]. Due to hormonal changes in pregnant
women, they are more susceptible to gingivitis and
periodontitis than non-pregnant women [78]. Indeed,
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evidence of periodontal disease [78].
Two different mechanisms have been proposed to explain
how oral health is associated with adverse pregnancy out-
comes. The first proposes that oral pathogens themselves can
translocate from an unhealthy oral cavity and cross the
placenta, reaching the intra-amniotic fluid and fetal circula-
tion [79]. The second hypothesizes that the systemic dissem-
ination of endotoxins or inflammatory mediators derived
from periodontal disease could affect development of the
fetus or spontaneous abortion [80].
Bacterial pathogens, antigens, endotoxins, and pro-
inflammatory cytokines produced during periodontal disease
can cross the placental barrier, resulting in disturbances in the
maternal-fetal unit that could contribute to adverse preg-
nancy outcomes [81,82]. F. nucleatum is the most common oral
pathogen found in a variety of placental and fetal tissues [77].
A case report of term stillbirth suggested that F. nucleatum
could translocate from the mother's mouth to the uterus
when her immune response was weakened during a respira-
tory infection [83]. Consistent with its high invasiveness, F.
nucleatum is repeatedly isolated from amniotic fluid and cord
blood in cases of preterm birth and neonatal sepsis [84,85].
Furthermore, F. nucleatum is often detected along with other
oral subspecies in intrauterine infections, which are likely
from the same infectious origin, implying co-translocation
from the oral cavity [77,85]. Other oral pathogens, such as P.
gingivalis (and its endotoxins), were also found in the placenta
of preterm delivery patients [86,87]. Studies in animal models
demonstrate the ability of P. gingivalis to impact negatively on
pregnancy: LPS from P. gingivalis induced placental and fetal
growth restriction and resorption in rats [88]; and antibodies
raised against P. gingivalis caused fetal loss when passively
administered into mice [89].
The maternal-fetal interface represents an immunologi-
cally unique site that must promote immune tolerance to the
fetus while at the same time maintaining a robust host de-
fense against possible infections. Even though little is known
about the role of innate immune receptors during pregnancy,
it was known that the placenta expresses Toll-like receptors
(TLRs) during normal pregnancy [90]. Periodontal disease or
the presence of periodontal pathogens such as T. denticola and
P. gingivalis have been shown to increase the expression of
TLRs [82,91], suggesting increased innate immune responses.
Although more studies will be required to establish
conclusively that there is a cause-and-effect relationship be-
tween periodontal disease and adverse pregnancy outcomes,
the results so far suggest that preventive measures against
periodontal disease in pregnant women are warranted.The oral cavity as a diagnostic tool
The realization that oral health is linked to systemic disease
and can affect the progression or development of diverse
diseases has led to the search for biomarkers in the oral cavity
that could detect systemic disease. The oral cavity is easily
accessible, allowing for non-invasive tests in most cases; and
patients usually visit dentists more often than general prac-
titioners. Thus, use of the oral cavity for early diagnosis ofsystemic disease should increase the likelihood of successful
treatment of many non-oral diseases.
The saliva is becoming an attractive diagnostic tool for
systemic disease, including cancer, bowel disease, diabetes,
neurodegenerative disease, and muscle and joint disease
[92,93] since the collection of saliva is quick, simple, and non-
invasive [94]. The analysis of multiple biomarkers in saliva
could help to detect the presence of several diseases simul-
taneously, and electrochemical sensor systems could quickly
detect salivary protein and genetic markers for diagnosis with
high specificity and sensitivity, allowing health care providers
to screen for systemic diseases easily and quickly [95].
Current progress has been made with the development of
“omics”-based markers for some diseases, such as OSCC [94].
Microbiomics, methylomics, and metabolomics, among other
high-throughput approaches, have shown promising poten-
tial for detection of some diseases, but further research is
needed in many cases to confirm the specific type of disease
[96e99]. Although this field is in its infancy, we are confident
that dental practitioners will soon be diagnosing many non-
oral systemic diseases in their clinic.Concluding remarks
A growing body of evidence in the literature shows the direct
and indirect impact of periodontal pathogens on overall
health. Recent epidemiological, clinical and experimental
studies support the relationship between bacteremia or
inflammation due to periodontal disease and systemic disease.
More studies are needed to elucidate themechanismswhereby
periodontal pathogens or the ensuing inflammation cause or
contribute to systemic disease. Nonetheless, it is already clear
that management of periodontal disease and proper oral care
can positively impact themorbidity, mortality, and health care
costs associated with non-oral systemic diseases.Conflicts of interest
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